Literature DB >> 2509909

Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes.

J A Lyon1, A W Thomas, T Hall, J D Chulay.   

Abstract

When malaria schizont-infected erythrocytes are cultured with immune serum, antibodies prevent dispersal of merozoites, resulting in the formation of immune clusters of merozoites (ICM) and inhibition of parasite growth. Antigens recognized by these antibodies were identified by probing two dimensional immunoblots of Plasmodium falciparum antigens with antibodies dissociated from immune complexes present at the surface of merozoites in ICM. Total immune serum recognized 88 of the 135 protein spots detected by colloidal gold staining, but antibodies dissociated from immune complexes recognized only 15 protein spots attributable to no more than eight distinct antigens. Antigens recognized by antibodies that inhibit merozoite dispersal include the precursor to the major merozoite surface antigens (gp195), a 126-kDa serine-repeat antigen (SERA), the 130-kDa protein that appears to bind to glycophorin (GBP130), and the approx. 45-kDa merozoite surface antigen. One other antigen (230/215-kDa doublet) was identified by using antibodies affinity purified from recombinant expression proteins. The identities of the other three antigens (150 kDa, 127 kDa and less than 30 kDa) were not determined. This approach provides a strategy for identifying epitopes accessible at the merozoite surface which may be important components of a multivalent vaccine against blood stages of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509909     DOI: 10.1016/0166-6851(89)90203-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  10 in total

1.  Immunomic Identification of Malaria Antigens Associated With Protection in Mice.

Authors:  Anthony Siau; Ximei Huang; Han Ping Loh; Neng Zhang; Wei Meng; Siu Kwan Sze; Laurent Renia; Peter Preiser
Journal:  Mol Cell Proteomics       Date:  2019-02-04       Impact factor: 5.911

2.  Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.

Authors:  A A Belperron; D Feltquate; B A Fox; T Horii; D J Bzik
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Antibodies reactive with the N-terminal domain of Plasmodium falciparum serine repeat antigen inhibit cell proliferation by agglutinating merozoites and schizonts.

Authors:  X L Pang; T Mitamura; T Horii
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Immunogenicity of the Plasmodium falciparum serine repeat antigen (p126) expressed by vaccinia virus.

Authors:  J A Tine; V Conseil; P Delplace; C De Taisne; D Camus; E Paoletti
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections.

Authors:  R Tolle; K Früh; O Doumbo; O Koita; M N'Diaye; A Fischer; K Dietz; H Bujard
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

6.  Anti-malarial market and policy surveys in sub-Saharan Africa.

Authors:  Graciela Diap; John Amuasi; Isaac Boakye; Ann-Marie Sevcsik; Bernard Pecoul
Journal:  Malar J       Date:  2010-04-23       Impact factor: 2.979

7.  Exploitation of a newly-identified entry pathway into the malaria parasite-infected erythrocyte to inhibit parasite egress.

Authors:  Svetlana Glushakova; Brad L Busse; Matthias Garten; Josh R Beck; Rick M Fairhurst; Daniel E Goldberg; Joshua Zimmerberg
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

Review 8.  Malarial proteases and host cell egress: an 'emerging' cascade.

Authors:  Michael J Blackman
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

9.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

10.  A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies.

Authors:  Tania F de Koning-Ward; Rebecca A O'Donnell; Damien R Drew; Russell Thomson; Terence P Speed; Brendan S Crabb
Journal:  J Exp Med       Date:  2003-09-08       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.